ACI
BNTX icon

AMP Capital Investors’s BioNTech BNTX Stock Holding History

AMP Capital Investors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,048
Closed -$286K – 310
2021
Q3 		$286K Sell
1,048
-160
-13% -$50.9K ﹤0.01% 1035
2021
Q2 		$270K Buy
+1,208
New +$228K ﹤0.01% 1083

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AMP Capital Investors's BNTX Position: Q4 2021 in Review

AMP Capital Investors sold out of BioNTech (BNTX) in Q4 2021, closing a stake of 1,048 shares — an estimated $286K sold.

AMP Capital Investors first reported a position in BNTX in Q2 2021 and held it in 2 quarters. The position peaked at $286K in Q3 2021. 354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

  • AMP Capital Investors reported no remaining BioNTech position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 1,048 BioNTech shares in Q4 2021, an estimated $286K.
  • AMP Capital Investors first reported a position in BioNTech in Q2 2021 and held it in 2 quarters.
  • AMP Capital Investors's BioNTech position peaked at $286K in Q3 2021.
  • 354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.